248 related articles for article (PubMed ID: 17548187)
1. Managing community-acquired pneumonia: a European perspective.
Lode HM
Respir Med; 2007 Sep; 101(9):1864-73. PubMed ID: 17548187
[TBL] [Abstract][Full Text] [Related]
2. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore.
Chiang WC; Teoh OH; Chong CY; Goh A; Tang JP; Chay OM
Respirology; 2007 Mar; 12(2):254-61. PubMed ID: 17298459
[TBL] [Abstract][Full Text] [Related]
4. Severe community-acquired pneumonia: an Australian perspective.
Wilson PA; Ferguson J
Intern Med J; 2005 Dec; 35(12):699-705. PubMed ID: 16313544
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones.
Carratalá J; Martín-Herrero JE; Mykietiuk A; García-Rey C
Clin Microbiol Infect; 2006 May; 12 Suppl 3():2-11. PubMed ID: 16669924
[TBL] [Abstract][Full Text] [Related]
6. Clinical and economic burden of community-acquired pneumonia among adults in Europe.
Welte T; Torres A; Nathwani D
Thorax; 2012 Jan; 67(1):71-9. PubMed ID: 20729232
[TBL] [Abstract][Full Text] [Related]
7. Community-acquired pneumonia in adolescents.
Gordon RC
Adolesc Med; 2000 Oct; 11(3):681-95. PubMed ID: 11060562
[TBL] [Abstract][Full Text] [Related]
8. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
[TBL] [Abstract][Full Text] [Related]
9. Empirical therapy of community-acquired pneumonia: macrolides are not ideal choices.
Bartlett JG
Semin Respir Infect; 1997 Dec; 12(4):329-33. PubMed ID: 9436960
[TBL] [Abstract][Full Text] [Related]
10. Community-acquired pneumonia: the U.S. perspective.
Niederman MS
Semin Respir Crit Care Med; 2009 Apr; 30(2):179-88. PubMed ID: 19296418
[TBL] [Abstract][Full Text] [Related]
11. Outcome analysis of patients requiring mechanical ventilation with severe community-acquired pneumonia and identified bacterial pathogens.
Hu HC; Huang CC; Tsai YH; Lee CH; Hsieh MJ
Chang Gung Med J; 2005 Apr; 28(4):229-36. PubMed ID: 16013342
[TBL] [Abstract][Full Text] [Related]
12. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
[TBL] [Abstract][Full Text] [Related]
13. Etiology of community-acquired pneumonia in hospitalized patients in Jordan.
Al-Ali MK; Batchoun RG; Al-Nour TM
Saudi Med J; 2006 Jun; 27(6):813-6. PubMed ID: 16758041
[TBL] [Abstract][Full Text] [Related]
14. Streptococcus pneumoniae: does antimicrobial resistance matter?
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
[TBL] [Abstract][Full Text] [Related]
15. [What is new in the treatment of community-acquired pneumonia?].
Welte T; Marre R; Suttorp N;
Med Klin (Munich); 2006 Apr; 101(4):313-20. PubMed ID: 16607488
[TBL] [Abstract][Full Text] [Related]
16. Severe community-acquired pneumonia (CAP) treated at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W; Pisprasert V
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):430-3. PubMed ID: 15691151
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region.
Song JH; Thamlikitkul V; Hsueh PR
Int J Antimicrob Agents; 2011 Aug; 38(2):108-17. PubMed ID: 21683553
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of the Japanese Respiratory Society guidelines for community pneumonia: a retrospective analysis of community-acquired pneumonia between 2000 and 2002 in a general hospital.
Motomura K; Masaki H; Terada M; Onizuka T; Furumoto A; Asoh N; Oishi K; Nagatake T
Respirology; 2005 Mar; 10(2):208-14. PubMed ID: 15823187
[TBL] [Abstract][Full Text] [Related]
19. Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance.
Asche C; McAdam-Marx C; Seal B; Crookston B; Mullins CD
J Antimicrob Chemother; 2008 May; 61(5):1162-8. PubMed ID: 18310136
[TBL] [Abstract][Full Text] [Related]
20. Clarithromycin in the management of community-acquired pneumonia.
McCarty JM
Clin Ther; 2000 Mar; 22(3):281-94; discussion 265. PubMed ID: 10963284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
